The Weekly Roundup: December 16-20

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

2024 Key Insights: Skin Cancer

Join Dermatology Times’ quarterly editor in chief Aaron Farberg, MD, as he highlights significant advancements in gene expression profile testing for cutaneous melanoma.

POLL: Is Your Practice Closed for the Holidays?

Answer this week's poll and read more about practice management around the holiday season.

Arcutis Submits sNDA for Roflumilast Cream 0.05% to FDA for Patients Ages 2 to 5 with Atopic Dermatitis

The supplemental New Drug Application is supported by positive results from the INTEGUMENT-PED and INTEGUMENT-OLE trials.

Navigating Psoriasis Treatment Across Patient Populations

Michael Lewitt, MD, FAAD, highlighted the importance of personalized care, the decision-making process in psoriasis treatment, and the role of patient education.

FDA Approves Tapinarof Cream, 1% for Atopic Dermatitis in Patients 2 Years and Older

The approval is based on positive data stemming from the ADORING clinical trial program.

The Burden of Prurigo Nodularis

Increased awareness for prurigo nodularis may help to usher in a new era of timelier and more targeted treatment.

ICYMI: FDA Approves Galderma's Nemolizumab for Moderate to Severe Atopic Dermatitis in Patients 12 and Older

Nemolizumab is intended for use in combination with topical corticosteroids and/or calcineurin inhibitors in this indication.

Plant-Based Products Can Be Especially Effective for Anti-Aging

Topical treatments with plant extracts improved skin hydration and elasticity while reducing melanin and erythema.

2024 Drug & Device Approvals in Review

Take a look back at this year's newly FDA-approved dermatology devices and drugs.

Treatment Insights and Evolving Care Options in Vitiligo

Karan Lal, DO; Lisa Swanson, MD; James Song, MD; Andrew Alexis, MD, MPH; and Lawrence Eichenfield, MD, discussed the complexities of vitiligo care and the potential of innovative topical therapies.

2024 Insights: Unmet Needs, Therapeutic Innovations, and Pivotal Findings in Chronic Hand Eczema

Catch up on exclusive interviews with Christopher Bunick, MD, PhD; Raj Chovatiya, MD, PhD; and Alexander Egeberg, MD, PhD, from quarter 4 dermatologic conferences.

Exploring EVO756 in Chronic Inflammatory Disease Treatment: Q&A with Evommune's Mark Jackson, MD

Jackson discusses EVO756, a promising MRGPRX2 antagonist targeting mast cells to treat chronic inflammatory diseases like spontaneous urticaria.

Wealth Strategies for Today’s Physician: David Mandell, JD, MBA, Shares Insights from New Playbook

The latest publication from OJM Group provides 7 core strategies for dermatologists looking to meet their financial goals.

Patients with Atopic Dermatitis Are More Susceptible to Developing Inflammatory Bowel Disease

In a meta-analysis of over 61 million participants, it was found that AD patients have a 37% risk of developing IBD and similar conditions.

Fighting the Flare of GPP: Expert Insights on Spesolimab

Experts discussed the challenges of managing GPP and highlight a pivotal study on the subcutaneous formulation of spesolimab, demonstrating its potential to prevent GPP flares and improve patient outcomes despite some limitations.

Enhancing Photodynamic Therapy With Red Light Applications, Patient Comfort, and Seasonal Trends

Experts highlight the versatility and patient-centered approach of PDT with red light, emphasizing its effectiveness for AK, skin rejuvenation, and superficial cancers.

Jason Hawkes, MD, MS: Looking Back on 2024, Ahead to 2025

Hawkes shared his excitement for the near future of dermatology, recognizing the increasing ability to provide tailored care to patients.

Systemic Review Further Confirms Sofpironium’s Safety and Efficacy in Hyperhidrosis Treatment

The new research identified notable improvements in disease severity, sweat reduction, and quality of life for patients treated with sofpironium.

The Importance and Role of Advocacy in the Approval of ICD-10 Codes for CCCA and FFA

Itisha S. Jefferson, a patient advocate and medical student, discusses the significance of new ICD-10 codes for CCCA and FFA, improving diagnosis and care.

Retirement Considerations for Dermatologists

With the right strategies and a clear vision, retirement can unfold as a rewarding chapter.

Improving Skin Radiance and Luminosity

In this month’s Cosmetic Conundrums column, learn how radiant, luminous skin can be achieved with cosmeceuticals.

FDA Gives Go-Ahead on Quoin Pharmaceuticals’ QRX003 Netherton Syndrome Study

The "whole body" study at Northwestern, led by Amy Paller, MD, begins soon.

2024 Expert Insights: More Options than Ever

Experts in the field shared insights with Dermatology Times on what they found most innovative, educational, and helpful in the past year.

Photodynamic Therapy is an Effective, Long-Term Treatment for Actinic Keratosis

Follow-up phase 3 data showed BF-200 ALA to be a safe and effective therapy for AK, when compared to placebo.

Interview Intersection: Expert Interviews From December 2024

Dermatology Times is recapping our top expert interviews from the month of December.

How OJM Group Can Help Dermatologists Reach Their Financial Goals in 2025 and Beyond

Trust and transparency are key in physician wealth management, according to David Mandell, JD, MBA.

InflaRx Advances INF904 for CSU and HS with Phase 2a Study

The company stated INF904 disrupts inflammatory pathways with over 90% effectiveness, based on Phase 1 data.

Dermatology Times December 2024 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of December.

Dispelling Skin Myths: A New Era of Preventative Care for Anti-Aging, Cleansing, and Sunscreen

Renata Block, MMS, PA-C; Ted Lain, MD, MBA, FAAD; Zoe Diana Draelos, MD; and Cheri Frey, MD, FAAD, bust common skin care myths in a Dermatology Times custom video series.